RT-001

N/A

Report date: 2025/02/28 11:24:51
NME

Base Information

Drug NameRT-001
Drug Alias NameDi-deuterated ethyl linoleateDi-deuterated linoleic acid ethyl esterD2-LART-001
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionFatty acid replacements
TargetsNot applicable
Therapy Area/IndicationsAmyotrophic Lateral SclerosisNeuroaxonal DystrophiesFriedreich Ataxia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenNetherlands +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRetrotope Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioJiva LLCRetrotope Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisNeuroaxonal DystrophiesFriedreich Ataxia
Inactive IndicationsSupranuclear Palsy, Progressive

Other Information

ATC CodeN/A
Related LinksN/A